KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Invested Capital (2016 - 2026)

ClearPoint Neuro's Invested Capital history spans 14 years, with the latest figure at $28.0 million for Q4 2025.

  • On a quarterly basis, Invested Capital rose 10.36% to $28.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.0 million, a 10.36% increase, with the full-year FY2025 number at $28.0 million, up 10.36% from a year prior.
  • Invested Capital hit $28.0 million in Q4 2025 for ClearPoint Neuro, up from $15.9 million in the prior quarter.
  • Over the last five years, Invested Capital for CLPT hit a ceiling of $58.6 million in Q4 2021 and a floor of $15.9 million in Q3 2025.
  • Historically, Invested Capital has averaged $38.5 million across 5 years, with a median of $42.3 million in 2023.
  • Biggest five-year swings in Invested Capital: skyrocketed 19686.08% in 2021 and later crashed 55.13% in 2025.
  • Tracing CLPT's Invested Capital over 5 years: stood at $58.6 million in 2021, then dropped by 20.2% to $46.8 million in 2022, then tumbled by 33.36% to $31.2 million in 2023, then decreased by 18.55% to $25.4 million in 2024, then increased by 10.36% to $28.0 million in 2025.
  • Business Quant data shows Invested Capital for CLPT at $28.0 million in Q4 2025, $15.9 million in Q3 2025, and $19.7 million in Q2 2025.